Global Cancer Vaccine Market & Clinical Trials Outlook 2028: HPV Vaccine Sales Fueling Growth With Other Investigational Vaccines in Late Stage Development – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Vaccine Market & Clinical Trials Outlook 2028” report has been added to ResearchAndMarkets.com’s offering. The global cancer vaccine market is expected to surpass US$ 15 Billion by 2028. The significant increase in the growth of the market is mainly attributed to encouraging sales of HPV cancer vaccines and rising awareness among … [Read more…]

InterVenn Expands Global Presence to Drive the Potential of Glycoproteomics to Improve Patient Outcomes

SAN FRANCISCO–(BUSINESS WIRE)–InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced that it has expanded its global presence with the opening of multiple new locations in Asia-Pacific and North America. The company’s new facilities include Mandaluyong, Philippines; Kuala Lumpur, Malaysia; Melbourne, Australia; and San Diego, California, adding a … [Read more…]

ATEC to Report Second Quarter 2022 Financial Results on August 4, 2022

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2022 financial results on August 4, 2022, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. … [Read more…]

AIM-HI Accelerator Fund Announces Lance Kawaguchi, CEO of Cure Brain Cancer Foundation, as New Strategic Advisor

ROCKVILLE, Md.–(BUSINESS WIRE)–AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today that Mr. Lance Kawaguchi, CEO of Cure Brain Cancer Foundation, has been appointed as a strategic advisor. AIM-HI’s prestigious strategic advisors are comprised of the world’s leaders in biotechnology commercialization and oncology … [Read more…]

Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event

COLLEGE STATION, Texas–(BUSINESS WIRE)–Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, hosted an inaugural event this week, Global Cell & Gene Day, with CHA Medical & Bio Group, providing a specialized venue for learning, innovation and networking for the … [Read more…]

Aural Analytics Partners with Medidata and its Sensor Cloud Network

Medidata Sensor Cloud Network to include Aural Analytics’ industry leading, integrated speech analytics platform—Speech Vitals. PHOENIX–(BUSINESS WIRE)–#AuralAnalytics—Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced they have entered into a partnership with Medidata, a Dassault Systèmes company, enabling speech analytics as part of the Medidata Sensor Cloud Network. Aural Analytics’ best-in-class speech platform Speech … [Read more…]

Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating HYQVIA® for Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

– Data Show that HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Reduced Relapse Rate Versus Placebo in CIDP Patients When Used as a Maintenance Therapy – Company Continues to Analyze Data with Goal of Submitting Regulatory Applications in the US and EU in FY2022 OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today … [Read more…]

Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2022 financial results will be released on Thursday, August 4, 2022, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and … [Read more…]

Ranpak Expands Automated Packaging Portfolio with Global Launch of the Flap’it!™ Solution

Innovative automated solution packages a variety of small products five times faster than manual packaging and delivers up to 50% cost reduction in materials CONCORD TOWNSHIP, Ohio–(BUSINESS WIRE)–Ranpak Holdings Corp. (“Ranpak”) (NYSE: PACK), a global leader of environmentally sustainable, paper-based packaging solutions for e-commerce and industrial supply chains, today announced the global launch of the … [Read more…]

IQVIA Reports Second-Quarter 2022 Results

Revenue of $3,541 million grew 3.0 percent year-over-year on a reported basis and 7.1 percent at constant currency GAAP Net Income of $256 million grew 46.3 percent year-over-year Adjusted EBITDA of $800 million grew 10.8 percent year-over-year GAAP Diluted Earnings per Share of $1.34 grew 48.9 percent year-over-year Adjusted Diluted Earnings per Share of $2.44 … [Read more…]